Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation.

Toffalori C, Zito L, Gambacorta V, Riba M, Oliveira G, Bucci G, Barcella M, Spinelli O, Greco R, Crucitti L, Cieri N, Noviello M, Manfredi F, Montaldo E, Ostuni R, Naldini MM, Gentner B, Waterhouse M, Zeiser R, Finke J, Hanoun M, Beelen DW, Gojo I, Luznik L, Onozawa M, Teshima T, Devillier R, Blaise D, Halkes CJM, Griffioen M, Carrabba MG, Bernardi M, Peccatori J, Barlassina C, Stupka E, Lazarevic D, Tonon G, Rambaldi A, Cittaro D, Bonini C, Fleischhauer K, Ciceri F, Vago L.

Nat Med. 2019 Apr;25(4):603-611. doi: 10.1038/s41591-019-0400-z. Epub 2019 Mar 25.

PMID:
30911134
2.

Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT.

Noviello M, Manfredi F, Ruggiero E, Perini T, Oliveira G, Cortesi F, De Simone P, Toffalori C, Gambacorta V, Greco R, Peccatori J, Casucci M, Casorati G, Dellabona P, Onozawa M, Teshima T, Griffioen M, Halkes CJM, Falkenburg JHF, Stölzel F, Altmann H, Bornhäuser M, Waterhouse M, Zeiser R, Finke J, Cieri N, Bondanza A, Vago L, Ciceri F, Bonini C.

Nat Commun. 2019 Mar 25;10(1):1065. doi: 10.1038/s41467-019-08871-1.

3.

DNA Vectors Generating Engineered Exosomes Potential CTL Vaccine Candidates Against AIDS, Hepatitis B, and Tumors.

Ferrantelli F, Manfredi F, Chiozzini C, Anticoli S, Olivetta E, Arenaccio C, Federico M.

Mol Biotechnol. 2018 Nov;60(11):773-782. doi: 10.1007/s12033-018-0114-3.

PMID:
30167966
4.

Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells.

Anticoli S, Aricò E, Arenaccio C, Manfredi F, Chiozzini C, Olivetta E, Ferrantelli F, Lattanzi L, D'Urso MT, Proietti E, Federico M.

J Mol Med (Berl). 2018 Feb;96(2):211-221. doi: 10.1007/s00109-017-1617-2. Epub 2017 Dec 27.

PMID:
29282521
5.

An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral Antigens.

Anticoli S, Manfredi F, Chiozzini C, Arenaccio C, Olivetta E, Ferrantelli F, Capocefalo A, Falcone E, Ruggieri A, Federico M.

Biotechnol J. 2018 Apr;13(4):e1700443. doi: 10.1002/biot.201700443. Epub 2018 Mar 24.

PMID:
29274250
6.

Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation.

Di Bonito P, Chiozzini C, Arenaccio C, Anticoli S, Manfredi F, Olivetta E, Ferrantelli F, Falcone E, Ruggieri A, Federico M.

Int J Nanomedicine. 2017 Jun 23;12:4579-4591. doi: 10.2147/IJN.S131309. eCollection 2017.

7.

Trans-dissemination of exosomes from HIV-1-infected cells fosters both HIV-1 trans-infection in resting CD4+ T lymphocytes and reactivation of the HIV-1 reservoir.

Chiozzini C, Arenaccio C, Olivetta E, Anticoli S, Manfredi F, Ferrantelli F, d'Ettorre G, Schietroma I, Andreotti M, Federico M.

Arch Virol. 2017 Sep;162(9):2565-2577. doi: 10.1007/s00705-017-3391-4. Epub 2017 May 4.

PMID:
28474225
8.

The CD8⁺ T Cell-Mediated Immunity Induced by HPV-E6 Uploaded in Engineered Exosomes Is Improved by ISCOMATRIXTM Adjuvant.

Manfredi F, di Bonito P, Ridolfi B, Anticoli S, Arenaccio C, Chiozzini C, Baz Morelli A, Federico M.

Vaccines (Basel). 2016 Nov 9;4(4). pii: E42.

9.

Incorporation of Heterologous Proteins in Engineered Exosomes.

Manfredi F, Di Bonito P, Arenaccio C, Anticoli S, Federico M.

Methods Mol Biol. 2016;1448:249-60. doi: 10.1007/978-1-4939-3753-0_18.

PMID:
27317186
10.

Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1.

Arenaccio C, Anticoli S, Manfredi F, Chiozzini C, Olivetta E, Federico M.

Retrovirology. 2015 Oct 26;12:87. doi: 10.1186/s12977-015-0216-y.

11.

The Contribution of Extracellular Nef to HIV-Induced Pathogenesis.

Olivetta E, Arenaccio C, Manfredi F, Anticoli S, Federico M.

Curr Drug Targets. 2016;17(1):46-53. Review.

PMID:
26424397
12.

HPV-E7 delivered by engineered exosomes elicits a protective CD8⁺ T cell-mediated immune response.

Di Bonito P, Ridolfi B, Columba-Cabezas S, Giovannelli A, Chiozzini C, Manfredi F, Anticoli S, Arenaccio C, Federico M.

Viruses. 2015 Mar 9;7(3):1079-99. doi: 10.3390/v7031079.

13.

Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism.

Arenaccio C, Chiozzini C, Columba-Cabezas S, Manfredi F, Affabris E, Baur A, Federico M.

J Virol. 2014 Oct;88(19):11529-39. doi: 10.1128/JVI.01712-14. Epub 2014 Jul 23.

14.

Cell activation and HIV-1 replication in unstimulated CD4+ T lymphocytes ingesting exosomes from cells expressing defective HIV-1.

Arenaccio C, Chiozzini C, Columba-Cabezas S, Manfredi F, Federico M.

Retrovirology. 2014 Jun 12;11:46. doi: 10.1186/1742-4690-11-46.

15.

Fostering locomotor behavior of children with developmental disabilities: An overview of studies using treadmills and walkers with microswitches.

Lancioni GE, Singh NN, O'Reilly MF, Sigafoos J, Didden R, Manfredi F, Putignano P, Stasolla F, Basili G.

Res Dev Disabil. 2009 Mar-Apr;30(2):308-22. doi: 10.1016/j.ridd.2008.05.002. Epub 2008 Jun 24.

PMID:
18573637
16.

A microswitch-cluster program to foster adaptive responses and head control in students with multiple disabilities: replication and validation assessment.

Lancioni GE, Singh NN, O'Reilly MF, Sigafoos J, Oliva D, Gatti M, Manfredi F, Megna G, La Martire ML, Tota A, Smaldone A, Groeneweg J.

Res Dev Disabil. 2008 Jul-Aug;29(4):373-84. Epub 2007 Aug 6.

PMID:
17681451
17.

A microswitch cluster to enhance arm-lifting responses without dystonic head tilting by a child with multiple disabilities.

Lancioni GE, Comes ML, Stasolla F, Manfredi F, O'Reilly MF, Singh NN.

Percept Mot Skills. 2005 Jun;100(3 Pt 1):892-4.

PMID:
16060461
18.

Adapting a grid into a microswitch to suit simple hand movements of a child with profound multiple disabilities.

Lancioni GE, O'Reilly MF, Singh NN, Stasolla F, Manfredi F, Oliva D.

Percept Mot Skills. 2004 Oct;99(2):724-8.

PMID:
15560365
19.

Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients.

Palange P, Valli G, Onorati P, Antonucci R, Paoletti P, Rosato A, Manfredi F, Serra P.

J Appl Physiol (1985). 2004 Nov;97(5):1637-42. Epub 2004 Jul 2.

20.

Hormonal changes with cholesterol reduction: a double-blind pilot study.

Ormiston T, Wolkowitz OM, Reus VI, Johnson R, Manfredi F.

J Clin Pharm Ther. 2004 Feb;29(1):71-3.

PMID:
14748901
21.

Behavioral implications of lowering cholesterol levels: a double-blind pilot study.

Ormiston T, Wolkowitz OM, Reus VI, Manfredi F.

Psychosomatics. 2003 Sep-Oct;44(5):412-4.

PMID:
12954916
22.

Ventilatory and metabolic adaptations to walking and cycling in patients with COPD.

Palange P, Forte S, Onorati P, Manfredi F, Serra P, Carlone S.

J Appl Physiol (1985). 2000 May;88(5):1715-20.

23.

Pulmonary gas exchange and exercise capacity in patients with systemic lupus erythematosus.

Forte S, Carlone S, Vaccaro F, Onorati P, Manfredi F, Serra P, Palange P.

J Rheumatol. 1999 Dec;26(12):2591-4.

PMID:
10606367
24.

Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women.

Costa MM, Reus VI, Wolkowitz OM, Manfredi F, Lieberman M.

Biol Psychiatry. 1999 Jul 15;46(2):182-8.

PMID:
10418692
25.

Antiglucocorticoid treatment of depression: double-blind ketoconazole.

Wolkowitz OM, Reus VI, Chan T, Manfredi F, Raum W, Johnson R, Canick J.

Biol Psychiatry. 1999 Apr 15;45(8):1070-4.

PMID:
10386195
26.

Elevated O2 cost of ventilation contributes to tissue wasting in COPD.

Mannix ET, Manfredi F, Farber MO.

Chest. 1999 Mar;115(3):708-13.

PMID:
10084480
27.

A comparison of two challenge tests for identifying exercise-induced bronchospasm in figure skaters.

Mannix ET, Manfredi F, Farber MO.

Chest. 1999 Mar;115(3):649-53.

PMID:
10084470
28.

Effect of reduced body weight on muscle aerobic capacity in patients with COPD.

Palange P, Forte S, Onorati P, Paravati V, Manfredi F, Serra P, Carlone S.

Chest. 1998 Jul;114(1):12-8.

PMID:
9674441
29.

Dehydroepiandrosterone (DHEA) treatment of depression.

Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Raum WJ, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H.

Biol Psychiatry. 1997 Feb 1;41(3):311-8.

PMID:
9024954
30.

Hemodynamic, renal, and hormonal responses to lower body positive pressure in human subjects.

Mannix ET, Farber MO, Aronoff GR, Brier ME, Weinberger MH, Palange P, Manfredi F.

J Lab Clin Med. 1996 Dec;128(6):585-93.

PMID:
8960642
31.

Dexamethasone for depression.

Wolkowitz OM, Reus VI, Manfredi F, Chan T, Ormiston S, Johnson R.

Am J Psychiatry. 1996 Aug;153(8):1112; author reply 1112-3. No abstract available.

PMID:
8678190
32.

Exercise-induced asthma in figure skaters.

Mannix ET, Farber MO, Palange P, Galassetti P, Manfredi F.

Chest. 1996 Feb;109(2):312-5.

PMID:
8620698
33.

Antidepressant and cognition-enhancing effects of DHEA in major depression.

Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H.

Ann N Y Acad Sci. 1995 Dec 29;774:337-9. No abstract available.

PMID:
8597481
34.

Oxygen effect on O2 deficit and VO2 kinetics during exercise in obstructive pulmonary disease.

Palange P, Galassetti P, Mannix ET, Farber MO, Manfredi F, Serra P, Carlone S.

J Appl Physiol (1985). 1995 Jun;78(6):2228-34.

PMID:
7665422
35.

Modulation of ATP production by oxygen in obstructive lung disease as assessed by 31P-MRS.

Mannix ET, Boska MD, Galassetti P, Burton G, Manfredi F, Farber MO.

J Appl Physiol (1985). 1995 Jun;78(6):2218-27.

PMID:
7665421
36.

Metabolic basis for inspiratory muscle fatigue in normal humans.

Mannix ET, Sullivan TY, Palange P, Dowdeswell IR, Manfredi F, Galassetti P, Farber MO.

J Appl Physiol (1985). 1993 Nov;75(5):2188-94.

PMID:
8307878
37.

Ketoconazole administration in hypercortisolemic depression.

Wolkowitz OM, Reus VI, Manfredi F, Ingbar J, Brizendine L, Weingartner H.

Am J Psychiatry. 1993 May;150(5):810-2.

PMID:
8480829
38.

Oxygen may lower the O2 cost of ventilation in chronic obstructive lung disease.

Mannix ET, Manfredi F, Palange P, Dowdeswell IR, Farber MO.

Chest. 1992 Apr;101(4):910-5.

PMID:
1555461
39.

The effect of oxygen with exercise on atrial natriuretic peptide in chronic obstructive lung disease.

Mannix ET, Manfredi F, Palange P, Aronoff GR, Weinberger MH, Farber MO.

Chest. 1992 Feb;101(2):341-4.

PMID:
1531190
40.

Antiglucocorticoid strategies in hypercortisolemic states.

Wolkowitz OM, Reus VI, Manfredi F, Ingbar J, Brizendine L.

Psychopharmacol Bull. 1992;28(3):247-51. Review.

PMID:
1480727
41.

Pharmacologic elevation of blood inorganic phosphate in hypoxemic patients with COPD.

Palange P, Carlone S, Serra P, Mannix ET, Manfredi F, Farber MO.

Chest. 1991 Jul;100(1):147-50.

PMID:
1905614
42.

Atrial natriuretic peptide and the renin-aldosterone axis during exercise in man.

Mannix ET, Palange P, Aronoff GR, Manfredi F, Farber MO.

Med Sci Sports Exerc. 1990 Dec;22(6):785-9.

PMID:
2149582
43.

Effect of positive and negative pressure breathing on sodium and water excretion.

Carlone S, Palange P, Mannix ET, Farber MO, Aronoff GR, Brier M, Serra P, Manfredi F.

J Lab Clin Med. 1990 Sep;116(3):298-304.

PMID:
2205694
44.

Atrial natriuretic peptide, renin and aldosterone in obstructive lung disease and heart failure.

Carlone S, Palange P, Mannix ET, Salatto MP, Serra P, Weinberger MH, Aronoff GR, Cockerill EM, Manfredi F, Farber MO.

Am J Med Sci. 1989 Oct;298(4):243-8.

PMID:
2529764
45.

Chest CT in the staging of lung cancer.

Farber MO, Manfredi F, Moak GD, Cockerill EM, Yaw PB.

Chest. 1985 Aug;88(2):162-3. No abstract available.

PMID:
4017665
46.

Renal and hormonal responses to acute hypoxia in normal individuals.

Ashack R, Farber MO, Weinberger MH, Robertson GL, Fineberg NS, Manfredi F.

J Lab Clin Med. 1985 Jul;106(1):12-6.

PMID:
2989395
47.

Effect of hypoxemia on sodium and water excretion in chronic obstructive lung disease.

Reihman DH, Farber MO, Weinberger MH, Henry DP, Fineberg NS, Dowdeswell IR, Burt RW, Manfredi F.

Am J Med. 1985 Jan;78(1):87-94.

PMID:
3966494
48.

In vitro elevation of red blood cell 2,3-diphosphoglycerate with fructose, phosphate, and methylene blue.

Farber MO, Rubin LR, Manfredi F.

Am J Hematol. 1984 Oct;17(3):261-7.

PMID:
6475937
49.

Effect of decreased O2 affinity of hemoglobin on work performance during exercise in healthy humans.

Farber MO, Sullivan TY, Fineberg N, Carlone S, Manfredi F.

J Lab Clin Med. 1984 Aug;104(2):166-75.

PMID:
6431044
50.

Hormonal abnormalities affecting sodium and water balance in acute respiratory failure due to chronic obstructive lung disease.

Farber MO, Weinberger MH, Robertson GL, Fineberg NS, Manfredi F.

Chest. 1984 Jan;85(1):49-54.

PMID:
6690251

Supplemental Content

Loading ...
Support Center